메티실린 내성 황색 포도알균에 의한 연조직 및 골 감염에 대한 전환요법으로서의 경구 Rifampin의 유용성

손종원,김신우,하상우,이응갑,정덕원,장현하,이종명,김능수 대한감염학회 2005 감염과 화학요법 Vol.37 No.6

목적 : 메티실린 내성 황색 포도알균에 의한 연조직및 골 감염의 치료 시 glycopeptide약물의 정주 요법에 이은 경구 항생제로의 처방 전환이 요구되는 경우가 많으나 마땅한 경구 약제의 선택이 어려운 실정이다. 이에 경구 rifampin을 메티실린 내성 황색 포도알균에 의한 연조직 및 골 감염에 사용하여 치료한 경우를 분석하여 그 유용성 정도와 실패한 경우 실패의 위험인자를 알아보고자 하였다. 재료 및 방법 : 2001년 1월부터 2004년 9월까지 메티실린 내성 황색 포도알균에 의한 연조직 및 골 감염 환자를 대상으로 rifampin을 그 치료 목적으로 사용한 44명의 환자를 의무 기록과 X선 사진을 통해 후향적으로 분석하였다. 기초 자료를 분석하였고 감염이 재발하여 치료 실패로 판정된 환자들에 대해 치료 실패의 원인이 될 만한 주요 변수에 대한 Chi-square 검증과 로지스틱 회귀분석을 시행하였다. 결과 : 치료 후 재발은 20.5% (8/39)였으며 재발 예와 사망에 대한 위험요소에 대한 단변량 분석에서 고관절 보형물이 있는 경우 흔하였으나 통계적 차이에는 미치지 못하였다(P=0.065). 고관절 보형물 외에 동반된 질환들, 쇼크의 동반, 균혈증의 동반, 경구 시 ciprofloxacin과 rifampin의 병합 복용 기간 등을 혼란 변수로 사용한 다변량 로지스틱 회귀분석에서는 고관절 보형물 만이 통계적으로 유의하였다(P=0.044). 결론 : 메티실린 내성 황색 포도알균에 의한 연조직및 골 감염에 rifampin과 다른 약제를 병합하여 치료하는 경우 재발은 적었다. 치료 실패의 경우는 고관절 부위 감염과 같이 보형물을 쉽게 제거하기 어려운 상황과 관계되는 것을 보여준다. Background : Rifampin is sometimes used in combination with other anti-staphylococcal agents to treat methicillin-resistant Staphylococcus aureus (MRSA) infections but few reports are available about the usefulness of rifampin against MRSA infections, especially in soft tissue and bone infections. Thus, we evaluated the efficacy of rifampin as switch therapy for soft tissue and bone infections caused by MRSA and assessed the risk factors for treatment failure. Materials and Methods : We retrospectively studied 44 patients who had soft tissue and bone infections caused by MRSA and were treated with rifampin in combination or as monotherapy as switch therapy from January 2001 to September 2004. Results : The mean age of the subjects was 50.2 years and the number of male and female were 34 and 10, respectively. Median duration of rifampin use was 32 days and 25% of the patients had artificial prostheses. Thirty one patients (79.5%, 31/39) were cured with parenteral glycopeptide followed by rifampin in combination or as monotherapy. Eight patients (8/39) recurred after the completion of treatment. The presence of hip prosthesis was the only significant risk factor (P= 0.027) in multivariate logistic regression test. Rifampin was tolerable in all cases. Conclusion : Rifampin as switch therapy for soft tissue and bone infection caused by MRSA was effective in 79.5% (31/39) of sujects. The treatment failure seems to be associated with unremovable infected prosthesis.

실내환경중의 산소발생기 사용에 대한 인식도 평가

손종렬,조윤수,이규현,황상용 대한위생학회 2003 대한환경위생공학회지 Vol.18 No.4

Recently, Indoor air quality(IAQ) in workplace, residential environments and office has been concern of people, scientists and related the public. The oxygen in air was very important and essential element in every aspect of life. This study was performed on a questionnaire survey of 400 people about their awareness of indoor air quality, oxygen generators and measured of oxygen concentration in indoor environment. The results obtained were as follows; As respondents are having their 90% of daytime indoors a day, and 80% of them can feel indoor air pollutions degrees directly by particle matters. The control of most important problems of IAQ was the poor ventilation. We know that 22% of the respondents was recognized the oxgen generator. And for the installation of indoor pollution control equipment, 20% of all respondents installed oxygen generators because almost respondents was not satified the trust of ability purified indoor air pollutants. In the experimental results, it was found that the oxygen concentration of sampling sites were in the range of 20~23.5%. Therefore, it was recommended that the government related IAQ was suggested the guideline and control of oxygen generators. Finally, it appeared that the oxygen generators using indoor environment can be applied to new technology for cleaning of indoor air.

일차성 식도이완불능증의 풍선확장술후 치료효과의 객관적 평가지표

손영해,나호영,조성범,주영은,김현수,최성규,유종선,김세종 全南大醫大 2001 전남의대학술지 Vol.37 No.2

절삭력에 의한 마이크로 엔드밀 변형에 관한 연구

손종인,이학용,손현승,서태일,윤길상 한국공작기계학회 2008 한국공작기계학회 추계학술대회논문집 Vol.2008 No.-

Micro end-milling has been becoming an important machining process to manufacture a number of small products such as micro-devices, bio-chips, micro-patterns and so on. Despite the importance of micro end-milling, many related researches have given grand efforts to micro end-milling phenomenon, for example, micro end-milling mechanism, cutting force modeling and machinability. This paper strongly concerned actual problem, micro tool deflection, which causes excessive machining errors on the workpiece. To research this problem, we measured cutting forces in micro end-milling processes. And then we measured about cutting profile for that processes. At last we make a comparison between tool deflection due to cutting force and measurement of cutting profile.

미니동종 조혈모세포 이식에서 T림프구 수용체 단클론성 항체의 이용 가능성 및 혼합 림프구 배양에서 림프구 억제효과에 대한 연구

손상균,박성원,백진호,김동환,정진태,현동우,곽동석,이재태,이규보 대한조혈모세포이식학회 1999 대한조혈모세포이식학회지 Vol.4 No.2

연구배경: 조혈모세포이식 및 조건화 치료는 원발성 질환을 제거 후 새로운 조혈세포를 이용한 공간을 마련하고 세포의 생착을 이름으로써 치료의 목표를 달성하고자 하나 심한 부작용으로 인한 높은 조기 사망률은 극복하여야 할 점이다. 저독성 조건화 처치를 하면 불충분한 면역세포의 살해로 인한 거부반응이 큰 문제가 된다. 이에 거부반응 및 이식편대숙주반응의 중요한 역할을 하는 림프구에 대한 억제작용을 갖는 단클로성 항체의 생체 내에서 효과를 추측하기 위해 DLA(Dog lymphocyte Antigen) mismatched dog의 말초혈액을 이용한 MLC assay를 시행하였다. 방법: DLA typing의 결과와 비교하기 위해 단클론성 항체 첨가 없이 DLA가 서로 다른 3마리의 말초혈액을 이용하여 서로의 MLC 반응을 비교 실험하였다. T림프구 수용체에 대한 단클론성 항체의 농도에 따른 proloferation 억제효과를 보기 위해 2, 10, 20, 200ug/ml의 농도로 DM5 (antigranulocyte antbody: 음성 대조군)와 비교하였다. 항원에 감작된 림프구에서의 D5에 대한 효과를 보기위해 장기 골수 배양 배지에서 responder를 stimulator 및 D5와 함께 3일간 배양후 세척하고 2일간의 배양후 다시 stimulator로서 재자극 후 5일 뒤에 proliferation assay를 시행하였다. 실제 이식을 시행한 donor 및 recipient의 세포를 분리하여 proliferation assay를 하여 이식 전후를 비교하였다. 결과: T림프구 수용체에 대한 단클론성 항체의 농도를 달리한 실험에서 2, 10 ,20ug/ml 모두에서 같은 농도의 DM5는 억제효과가 없는데 비해상 당한 림프구증식 억제효과가 관찰되었다. In vivo 실험에서 중용량의 방사성 치료 및 면역 억제 요법으로 DLA matched 2마리 모두에서 성공적인 생착을 확인하였다. 공여자의 mismatched sample에 대해 G-CSF를 이용한 가동화 치료전 보다 낮은 proliferation score를 보였다. 결론: T림프구 수용체에 대한 단클론성 항체는 In vitro 실험에서 T림프구의 억제효과가 관찰되었고 동물 이식에서 부작용을 줄이는 저용량의 조건화 치료 후 생착을 유도하는 면역억제제로서 그 가능성을 확인하였고 향후 그 기전에 대한 연구 및 많은 생체 실험이 필요하다고 생각된다. 재생불량성 빈혈 같은 저세포 충실도의 골수 질환이나 과거에 방사선 치료를 심하게 받은 경우는 이미 골수 내 생착을 위한 공간이 마련된 상태이므로 특별한 면역억제 요법이 가능하다면 이러한 저독성의 조건화 처치가 유용하게 응용될수 있을 것으로 전망된다. Background: The objective of this study was to evaluate the effect of anti-TCR monoclonal antibody in mixed lymphocyte culture and as a part of immunosuppressive regimens in the allogeneic stem cell transplantation. Since marrow space is empty in the patients with aplastic anemia or previous radiation and no new space for allograft needs to be created, nontoxic imminosuppressive conditioning regimens should be feasible. These may include monoclonal antibody directed against T cell receptor other surface determinants on T cell. Moncoclonal antibody (MAb) 15.9D5 raised to canine TCR α β was found to induce hyporesponsiveness to allogeneic stimulator cells in primary and secondary mixed lymphocyte culture (MLC). Methods: Anti-TCR monoclonal antibody was tested to evaluate its suppressive effect of lymphocyte activity in vitro compared with anti- granulocyte anti body and used as an immuno-suppressive agent in two recipient dogs. Four different concentration of anti-TCR MAbs was tested in MLC to know the appropriate concentration for suppressing lymphocyte proliferation, and MLC assays were serially done from blood sample of recipient dogs and donor dogs before and after transplantation. Results: Anti-TCR monoclonal antibody had significantly suppressed H3-thymidine uptake in MLC compared with anti-granulocyte antibody(control). In two recipient dogs conditioned with non-myeloablative regimens and MAb, transplanted with DLA- matched donor dogs, successful mobilizing stem cells were less reactive to the stimulator lymphocytes than the lymphocytes from the dogs not treated before. Conclusion: The precise mechanism of immunosuppression induced by anti- TCR MAb needs to be elucidated. G-CSF had a role in suppressing lymphocyte activity of donor dogs and might have a role in preventing GVHD. Non-myeloablative conditioning strategy might be useful in patients with hypoplastic marrows who require immunosuppression only (e. g. aplastic anemia) and already has some spaces for engraftment in the marrow (e. g. irradiated marrows).

忠州市 主幹線 道路邊 建築外部色彩에 關한 硏究

崔生吉,孫泰鎭,柳顯紀,辛同寅,梁富弘,尹勝照,朴碩鉉 忠州大學校 1998 한국교통대학교 논문집 Vol.33 No.2

In order to understand the influence of colours on the urban design of a city, a portion of the central Chung-Ju was chosen as the study area, and three cases were researched as colours. These surveyed colours are analysed in their hue, value and chroma. It was necessary to determine the colours of 272 buildings exterior in all in order formulate the findings presented in this study. The result of this study can be briefly summerised as the following ; 1) The trends in the use of colour turn out like this ; 55.3% of the building were Y(yellow), YR(yellow-green), R(red) Family in Hue, abour 33.9% of them were within 8.0-8.9 and 26.6% were within 7.0-7.9 on the value scale, and about 48.5% of them were within 1.0-1.9, 2.0-2.9 and 3.0-3.9 on the chroma scale. 1) For case 1 on the exterior colours of buildings, about 57.8% were Y and YR family in Hue, about 53.7% were 8.0-8.9 and 7.0-7.9 in Value, and about 49.6% of them were within 1.0-3.9 in chroma. 2) For case 2 on the exterior colours of buildings, about 52.4% were Y and R family in Hue, about 65.1% were 7.0-8.9 in Value, and about 46% were 1.0-2.9 in Chroma. 3) For case 3 on the exterior colours of buildings, about 55.7% were Y and YR Family in Hue, about 72.1% were 7.0-8.9 in Value, and about 31.1% were 2.0-2.9 in Chroma. In summary, the colours of the building surveyed in central Chung-Ju can be characerized as Y, YR, R, N family in Hue, 7.0-7.9, 8.0-8.9 in Value registered in 1.0-1.9, 2.0-2.9, 3.0-3.9 in Chroma. The observed exterior colours show a tendency toward Yellow in Hue, High in Value and low in Chroma. Generally, the majority of the colours is light rather than strong in tone.

ZnS : DyF₃ 교류 박막 EL소자의 제작과 특성조사

현동걸,손상호,박태성,이동헌 경북대학교 산업기술연구소 1990 産業技術硏究誌 Vol.18 No.-

EL device of which rare-earth floride DyF_3 doped in ZnS host is fabricated and measured its electric and optical characterics in our experiment. Its optical spectrum is depend on active layer and host, and the changes of the substrate te,perature during fulfilled deposition process is partcipated improving of crystallity of the active active layer. Annealing processes help removing the film distortion of active layer and improve the crystallity of internal of the grain. However, it may not affect the changes of the grain size. The enhamcement of crystallity resulted from the changes of the substrate temperature and the re-crystallization of luminance center be caused by annealing improved brightness and efficiency of EL device. Brightness of which device constructed in our experiment is 128cd/㎡ in 1KHz sinusoidal wave. And it emited whitish-yellow light which wavelength is 570㎚.

플라즈마 표지소자의 제작

이상윤,라병욱,박동수,황인헌,이덕동,신영남,박성배,이동욱,박용석,박형근,손상호,권태근,채경락,정경득 慶北大學校 自然科學大學 1986 自然科學論文集 Vol.4 No.-

An Ac-type Plasma Display Panel (PDP) operating with Ne-Ar(0.1%) Penning mixture gas is fabicated. The characterics of the panel with electrodes covered with thin and thick dielectric layers are studied. The brightness of the Neon-orange light emitted by the panel measured as function of applied voltage and frequency. As an application, a graphic display system equipped with PDP showing still and moving pictures is made.

한국인의 우울증 진단기준의 특성

장성만,손지훈,이준영,최지환,조성진,전홍진,함봉진,이동현,조맹제 大韓神經精神醫學會 2007 신경정신의학 Vol.46 No.5

목적 국내의 여러 역학 조사에 따르면 한국인은 서구에 비하여 우울증의 유병률이 낮은 것으로 보고되고 있다. 낮은 유병률에 대하여 서구에서 정의하는 우울증의 진단 기준이 한국인의 문화에 맞지 않다는 진단 기준의 오류를 제시하거나, 실제로 유병률이 낮다는 설명을 시도하기도 하였다. 본 연구는 DSM-IV에서 제시하는 우울증의 진단 기준에 대하여 한국인의 반응 특성을 알아보고자 한다. 방법 2001년 KECA 연구에 응답한 만 18세 이상 65세 미만의 6,275명을 대상으로 하였다. 한국어판 CIDI (K-CIDI)를 통해 정신장애의 이환을 진단하였으며, K-CIDI 내의 우울장애 진단 기준만을 추출하여 분석하였다. 분석은 문항반응이론(Item Response Theory)을 적용하였다. 결과 한국인에서 DSM-IV의 주요우울장애 진단 기준의 오류는 없었으나, 진단 기준의 역치는 높았다. 한국인이 호소하는 우울증상으로서 "피로감"과 "집중력 저하", "수면 변화"는 진단되는 우울증의 초기부터 잘 나타나는 증상 들이며, "정선운동변화", "죽음/자살사고", "무가치함/죄책감"은 보다 심한 우울증에서 잘 나타나는 증상들이었다. 결론 DSM-IV가 제시하는 주요우울장애 진단 기준은 한국인의 우울증을 평가하는 데 있어 타당하기는 하나, 진단 기준의 역치가 높다. 우울증의 중증도에 따라 호소하는 증상들이 달랐다. Baekgrounds : Many Korean epidemiologic studies reported lower prevalence rates of depression than those of Western countries. For the low prevalence, it is explained that there's something wrong in the direct application of diagnostic criteria of depression to Korean culture, i.e. categorical fallacy, or it may be truly low-prevalent. We will analyze diagnostic criteria for depression detined by Western. Methods : Six thousand and two hundred seventy-five cummunity dwelling subjects, aged 18-64 years were interviewed by using Korean version of Composite International Diagnostic Interview (K-CIDI). Diagnostic criteria for depression defined by DSM-IV were analyzed using the item response theory. Rcsults : We could not find any fallacies of diagnostic critcria tbr depression defined by DSM-IV when assessing depre-ssion among Koreans. Fatigue, concentration difficultics, and sleep disturbance appeared more fequently in mild depression, while psychomotor change, death/suicide, and worthlessness/guilt did not appear until severe depression. Cunclusion : The diagnostic criteria for depression defined by DSM-IV arc appropriate for the Koreans. There are different responding levels, i.e. threshold, of depressive criteria according to severities of depression. Koreans with depression are more likely to complain of appetite change, but less of worthless or guilty feelings than Western people.

Bortezomib과 Dexamthasone으로 치료한 골수외 형질세포종 4예

백종현,이은영,장리라,손창배,신은경,서정아,이지숙,이호섭,이상민,신성훈,김양수 고신대학교의과대학 2007 고신대학교 의과대학 학술지 Vol.22 No.2

Despite the use of aggressive local and systemic treatment including autologous stem cell transplantation in multiple myeloma, extramedullary recurrences are common and the prognosis of these patients is poor. Many novel drugs such as thalidomide, lenalidomide and bortezomib improve the response of treatment of multiple myeloma, but some reports failed to describe thalidomide has effect in extramedullary plasmacytoma. Recent data report on the successful treatment plasmacytomas with bortezomib in patients with advanced multiple myeloma. We treated 4 relapsed or refractory extramedullary plasmacytomas with bortezomib at our institution. We recognized all these extramedullary plasmacytomas decreased and showed more than partial response. This report lends support to the efficacy of bortezomib in the treatment of plasmacytoma and describes the safe use of bortezomib. Responses may, however, be of short duration. Therefore, despite our limited experience, we propose that bortezomib may be considered a therapeutic option for such patients who have risk of radiation therapy